Y-mAbs Therapeutics In-Person Research & Development Day
About The Event
8:30 AM ET – Breakfast/Check-In
9:00 AM ET – 11:00 AM ET – Presentations
Y-mAbs Therapeutics invites you to their annual R&D Day, featuring presentations of the company, its clinical development and advanced product pipeline.
- Thomas Gad (Founder, President, and Interim Chief Executive Officer at Y-mAbs Therapeutics) will give a corporate presentation.
- Steen Lisby, M.D., DMSc, (SVP, Chief Scientific Officer at Y-mAbs Therapeutics) will present pipeline news and an overview of the investigational SADA technology platform (Liquid RadiationTM).
- Vignesh Rajah, MBBS, DCH, MRCP (UK) MBA, (SVP, Chief Medical Officer at Y-mAbs Therapeutics), will present an update on the potential DANYELZA® (naxitamab-gqgk) label expansion into osteosarcoma, which is investigational, and a multicenter Phase 2 trial in patients with newly diagnosed high-risk neuroblastoma.
A question-and-answer session will follow the formal presentations.